United States · FDA National Drug Code directory
Aripiprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76483-102_d7622fbb-a43c-46db-bde4-d05ed7bff185
- Product NDC
- 76483-102
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Aripiprazole
- Labeler
- SQUARE PHARMACEUTICALS LIMITED
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220720
- Source listing expiry
- 20261231
Source-listed ingredients
- ARIPIPRAZOLE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-00) · 76483-102-00
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-01) · 76483-102-01
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-02) · 76483-102-02
- 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-03) · 76483-102-03
- 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (76483-102-04) · 76483-102-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →